Cargando…

The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control

BACKGROUND: Trachoma, the worldwide leading infectious cause of blindness, is due to repeated conjunctival infection with Chlamydia trachomatis. The effects of control interventions on population levels of infection and active disease can be promptly measured, but the effects on severe ocular sequel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambhir, Manoj, Basáñez, Maria-Gloria, Burton, Matthew J., Solomon, Anthony W., Bailey, Robin L., Holland, Martin J., Blake, Isobel M., Donnelly, Christl A., Jabr, Ibrahim, Mabey, David C., Grassly, Nicholas C.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691478/
https://www.ncbi.nlm.nih.gov/pubmed/19529762
http://dx.doi.org/10.1371/journal.pntd.0000462
_version_ 1782167874181267456
author Gambhir, Manoj
Basáñez, Maria-Gloria
Burton, Matthew J.
Solomon, Anthony W.
Bailey, Robin L.
Holland, Martin J.
Blake, Isobel M.
Donnelly, Christl A.
Jabr, Ibrahim
Mabey, David C.
Grassly, Nicholas C.
author_facet Gambhir, Manoj
Basáñez, Maria-Gloria
Burton, Matthew J.
Solomon, Anthony W.
Bailey, Robin L.
Holland, Martin J.
Blake, Isobel M.
Donnelly, Christl A.
Jabr, Ibrahim
Mabey, David C.
Grassly, Nicholas C.
author_sort Gambhir, Manoj
collection PubMed
description BACKGROUND: Trachoma, the worldwide leading infectious cause of blindness, is due to repeated conjunctival infection with Chlamydia trachomatis. The effects of control interventions on population levels of infection and active disease can be promptly measured, but the effects on severe ocular sequelae require long-term monitoring. We present an age-structured mathematical model of trachoma transmission and disease to predict the impact of interventions on the prevalence of blinding trachoma. METHODOLOGY/PRINCIPAL FINDINGS: The model is based on the concept of multiple reinfections leading to progressive conjunctival scarring, trichiasis, corneal opacity and blindness. It also includes aspects of trachoma natural history, such as an increasing rate of recovery from infection and a decreasing chlamydial load with subsequent infections that depend upon a (presumed) acquired immunity that clears infection with age more rapidly. Parameters were estimated using maximum likelihood by fitting the model to pre-control infection prevalence data from hypo-, meso- and hyperendemic communities from The Gambia and Tanzania. The model reproduces key features of trachoma epidemiology: 1) the age-profile of infection prevalence, which increases to a peak at very young ages and declines at older ages; 2) a shift in this prevalence peak, toward younger ages in higher force of infection environments; 3) a raised overall profile of infection prevalence with higher force of infection; and 4) a rising profile, with age, of the prevalence of the ensuing severe sequelae (trachomatous scarring, trichiasis), as well as estimates of the number of infections that need to occur before these sequelae appear. CONCLUSIONS/SIGNIFICANCE: We present a framework that is sufficiently comprehensive to examine the outcomes of the A (antibiotic) component of the SAFE strategy on disease. The suitability of the model for representing population-level patterns of infection and disease sequelae is discussed in view of the individual processes leading to these patterns.
format Text
id pubmed-2691478
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-26914782009-06-15 The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control Gambhir, Manoj Basáñez, Maria-Gloria Burton, Matthew J. Solomon, Anthony W. Bailey, Robin L. Holland, Martin J. Blake, Isobel M. Donnelly, Christl A. Jabr, Ibrahim Mabey, David C. Grassly, Nicholas C. PLoS Negl Trop Dis Research Article BACKGROUND: Trachoma, the worldwide leading infectious cause of blindness, is due to repeated conjunctival infection with Chlamydia trachomatis. The effects of control interventions on population levels of infection and active disease can be promptly measured, but the effects on severe ocular sequelae require long-term monitoring. We present an age-structured mathematical model of trachoma transmission and disease to predict the impact of interventions on the prevalence of blinding trachoma. METHODOLOGY/PRINCIPAL FINDINGS: The model is based on the concept of multiple reinfections leading to progressive conjunctival scarring, trichiasis, corneal opacity and blindness. It also includes aspects of trachoma natural history, such as an increasing rate of recovery from infection and a decreasing chlamydial load with subsequent infections that depend upon a (presumed) acquired immunity that clears infection with age more rapidly. Parameters were estimated using maximum likelihood by fitting the model to pre-control infection prevalence data from hypo-, meso- and hyperendemic communities from The Gambia and Tanzania. The model reproduces key features of trachoma epidemiology: 1) the age-profile of infection prevalence, which increases to a peak at very young ages and declines at older ages; 2) a shift in this prevalence peak, toward younger ages in higher force of infection environments; 3) a raised overall profile of infection prevalence with higher force of infection; and 4) a rising profile, with age, of the prevalence of the ensuing severe sequelae (trachomatous scarring, trichiasis), as well as estimates of the number of infections that need to occur before these sequelae appear. CONCLUSIONS/SIGNIFICANCE: We present a framework that is sufficiently comprehensive to examine the outcomes of the A (antibiotic) component of the SAFE strategy on disease. The suitability of the model for representing population-level patterns of infection and disease sequelae is discussed in view of the individual processes leading to these patterns. Public Library of Science 2009-06-16 /pmc/articles/PMC2691478/ /pubmed/19529762 http://dx.doi.org/10.1371/journal.pntd.0000462 Text en Gambhir et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gambhir, Manoj
Basáñez, Maria-Gloria
Burton, Matthew J.
Solomon, Anthony W.
Bailey, Robin L.
Holland, Martin J.
Blake, Isobel M.
Donnelly, Christl A.
Jabr, Ibrahim
Mabey, David C.
Grassly, Nicholas C.
The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control
title The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control
title_full The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control
title_fullStr The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control
title_full_unstemmed The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control
title_short The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control
title_sort development of an age-structured model for trachoma transmission dynamics, pathogenesis and control
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691478/
https://www.ncbi.nlm.nih.gov/pubmed/19529762
http://dx.doi.org/10.1371/journal.pntd.0000462
work_keys_str_mv AT gambhirmanoj thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT basanezmariagloria thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT burtonmatthewj thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT solomonanthonyw thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT baileyrobinl thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT hollandmartinj thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT blakeisobelm thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT donnellychristla thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT jabribrahim thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT mabeydavidc thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT grasslynicholasc thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT gambhirmanoj developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT basanezmariagloria developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT burtonmatthewj developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT solomonanthonyw developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT baileyrobinl developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT hollandmartinj developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT blakeisobelm developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT donnellychristla developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT jabribrahim developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT mabeydavidc developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol
AT grasslynicholasc developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol